Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Works matching IS 0008543X AND DT 2006 AND VI 107 AND IP 5
Results: 26
1
2
Diagnosis of clear cell sarcoma by real‐time reverse transcriptase‐polymerase chain reaction analysis of paraffin embedded tissues: Clinicopathologic and molecular analysis of 44 patients from the French sarcoma group.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1055
- By:
- Publication type:
- Article
3
Response to low‐dose ketoconazole and subsequent dose escalation to high‐dose ketoconazole in patients with androgen‐independent prostate cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 975
- By:
- Publication type:
- Article
4
Malignant peripheral nerve sheath tumors: Prognostic factors and survival in a series of patients treated at a single institution.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1065
- By:
- Publication type:
- Article
5
Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB‐IV nonsmall cell lung cancerInformed consent was obtained from the subjects and/or guardians.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1050
- By:
- Publication type:
- Article
6
The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1023
- By:
- Publication type:
- Article
7
A phase I/II study of weekly high‐dose erlotinib in previously treated patients with nonsmall cell lung cancerPresented in part at the 2004 American Society of Clinical Oncology Meeting, New Orleans, Louisiana, June 5–8, 2004.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1034
- By:
- Publication type:
- Article
8
Deficiencies in myeloid antigen‐presenting cells in women with cervical squamous intraepithelial lesionsThe Institutional Review Board of M. D. Anderson Cancer Center approved the study protocols and patients provided written informed consent before enrollment.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 999
- By:
- Publication type:
- Article
9
Phase II study of single‐agent bortezomib for the treatment of patients with fludarabine‐refractory B‐cell chronic lymphocytic leukemia.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 916
- By:
- Publication type:
- Article
10
Promoting culturally appropriate colorectal cancer screening through a health educator: A randomized controlled trial.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 959
- By:
- Publication type:
- Article
11
Secondary chromosomal abnormalities predict outcome in pediatric and adult high‐stage Burkitt lymphoma.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1084
- By:
- Publication type:
- Article
12
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomasThe authors dedicate this paper to Reza Parwaresch, who served as a reference pathologist for the German Low‐Grade Lymphoma Study Group (GLSG) over many years and who died unexpectedly in November 2005.: Results of a prospective randomized trial of the German Low‐Grade Lymphoma Study Group
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1014
- By:
- Publication type:
- Article
13
Elevated mRNA levels of DNA methyltransferase‐1 as an independent prognostic factor in primary nonsmall cell lung cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1042
- By:
- Publication type:
- Article
14
Role of angiogenesis in chronic lymphocytic leukemia.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 925
- By:
- Publication type:
- Article
15
Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum‐assisted, intact‐specimen breast biopsy devicePart of this study was presented at the Radiological Society of North America (RSNA), November, 2004.Informed consent was obtained before each procedure.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 945
- By:
- Publication type:
- Article
16
Should we screen for bladder cancer in a high‐risk population?: A cost per life‐year saved analysis.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 982
- By:
- Publication type:
- Article
17
Cancer incidence after localized therapy for prostate cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 991
- By:
- Publication type:
- Article
18
Family history of breast cancer as a risk factor for ovarian cancer in a prospective studyThe opinions or assertions contained herein are the personal conclusions of the authors and are not to be construed as official or reflecting the views of any state agency listed above.This article is a US Government work and, as such, is in the public domain in the United States of America.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1075
- By:
- Publication type:
- Article
19
Chemoprevention: Drug pricing and mortalityThe National Cancer Institute provided review of the article but had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; or preparation or approval of the article.: The case of tamoxifen
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 950
- By:
- Publication type:
- Article
20
Advances and surgical decision‐making for breast reconstruction.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 893
- By:
- Publication type:
- Article
21
Vinorelbine, doxorubicin, and prednisone in androgen‐independent prostate cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1093
- By:
- Publication type:
- Article
22
The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinomaPresented at the Western Thoracic Surgical Association, Victoria, Canada, June 22–25, 2005.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 967
- By:
- Publication type:
- Article
23
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 885
- By:
- Publication type:
- Article
24
A nonreplicating adenoviral vector that contains the wild‐type p53 transgene combined with chemotherapy for primary breast cancer: Safety, efficacy, and biologic activity of a novel gene‐therapy approach.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 935
- By:
- Publication type:
- Article
25
Current controversies in high‐dose‐rate versus low‐dose‐rate brachytherapy for cervical cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 908
- By:
- Publication type:
- Article
26
Sudden blast crisis in patients with Philadelphia chromosome‐positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1008
- By:
- Publication type:
- Article